Wheeler Bio, founded in 2020 by Jesse McCool in Oklahoma City, is a biomanufacturing company dedicated to accelerating therapeutic innovation. The company's core mission is to democratize access to comprehensive discovery-to-IND (Investigational New Drug) programs through its rapid and integrated biomanufacturing platform, Portable CMC®. Wheeler Bio offers a range of services including transient protein expression, cell line development, process development and optimization, analytical development, and GMP (Good Manufacturing Practice) material supply. Their market focus is on enabling faster and more efficient translation of pre-clinical discoveries into clinical applications.

Notable individuals affiliated with Wheeler Bio include its founder Jesse McCool, who brings significant expertise in biomanufacturing. The company has garnered attention from key investors and stakeholders in the biotech industry. Wheeler Bio's innovative approach has led to significant achievements in reducing the time and cost associated with bringing new therapeutics to clinical trials. By providing a streamlined and accessible pathway from discovery to clinical impact, Wheeler Bio is making a substantial impact on the biopharmaceutical landscape.